Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)

NCT02124759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Insulin Sensitivity

Interventions

DRUG: Sevelamer
DRUG: Synbiotic
DRUG: Maltodextrin
OTHER: High Fat diet
OTHER: Low Fat diet

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]